✦ LIBER ✦

Relapsed and secondary disease drive the risk profile for invasive aspergillosis prior to stem cell transplantation in patients with acute myeloid leukemia or myelodysplastic syndrome

✍ Scribed by van de Peppel, R. J.; Dekkers, O. M.; von dem Borne, P. A.; de Boer, M. G. J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cytoreductive treatment with clofarabine

✍ Stefanie Buchholz; Elke Dammann; Michael Stadler; Juergen Krauter; Gernot Beutel 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

Reduced-toxicity conditioning with treos

✍ Kröger, N; Shimoni, A; Zabelina, T; Schieder, H; Panse, J; Ayuk, F; Wolschke, C; 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 153 KB

Myeloablative Reduced-Toxicity i.v. Busu

✍ Gheath Alatrash; Marcos de Lima; Nelson Hamerschlak; Matteo Pelosini; Xuemei Wan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 360 KB

Combining Azacitidine (Vidaza®, Aza) and

✍ T. Schroeder; A.G. Czibere; N. Kröger; U. Platzbecker; G. Bug; L. Uharek; T. Luf 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 63 KB